NCT06834945

Brief Summary

The purpose of this study is to develop and refine a behavioral intervention to address fertility-related information needs and fertility-related distress among female adult survivors of childhood cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2025

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

February 10, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 19, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 28, 2025

Completed
Last Updated

July 20, 2025

Status Verified

May 1, 2025

Enrollment Period

4 months

First QC Date

February 10, 2025

Last Update Submit

July 18, 2025

Conditions

Keywords

Fertility ConcernsFertility Distress

Outcome Measures

Primary Outcomes (3)

  • Feasibility as measured by treatment attrition

    A treatment attrition rate of ≤ 20% will be indicative of preliminary intervention feasibility.

    Post-treatment, approximately 16 months

  • Feasibility as measured by session attendance

    A session attendance rate of ≥80% will be indicative of preliminary intervention feasibility.

    Post-treatment, approximately 16 months

  • Treatment acceptability as measured by Treatment Acceptability Questionnaire (TAQ)

    Acceptability will be measured by the Treatment Acceptability Questionnaire (TAQ), a six-item measure assessing perceptions of an interventions acceptability, ethics, and effectiveness. Items are rated on a 7-point Likert scale, from "very unacceptable" to "very acceptable". An average score of ≥5 will be indicative of treatment acceptability.

    Post-treatment, approximately 16 months

Secondary Outcomes (5)

  • Fertility health knowledge as measured by Modified Fertility and Infertility Treatment Knowledge Score (FIT-KS)

    Pre-treatment and post-treatment, approximately 16 months

  • Patient activation as measured by Short Form of the Patient Activation Measure

    Pre-treatment and post-treatment, approximately 16 months

  • Self-efficacy for communicating with medical providers as measured by a modified version of the Ask, Understand, Remember Assessment (AURA)

    Pre-treatment and post-treatment, approximately 16 months

  • Psychological flexibility as measured by the Acceptance and Action Questionnaire-II (AAQ-II)

    Pre-treatment and post-treatment, approximately 16 months

  • Fertility-related distress will be measured by the Reproductive Concerns after Cancer (RCAC)scale

    Pre-treatment and post-treatment, approximately 16 months

Study Arms (1)

AYA SPARK

EXPERIMENTAL

Participants will receive the AYA SPARK health intervention which includes six sessions delivered remotely (i.e., videoconferencing) by a clinical psychologist.

Behavioral: AYA SPARK

Interventions

AYA SPARKBEHAVIORAL

Intervention includes video conferencing based sessions to cover topics related to fertility-related information needs and concerns among female adult survivors of childhood cancer over a 6-8 week period.

AYA SPARK

Eligibility Criteria

Age18 Years - 44 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Currently aged 18-44
  • Diagnosed with cancer at \<18 years old
  • Female sex
  • Uncertain fertility status

You may not qualify if:

  • Age \<18
  • Currently under the care of a fertility specialist
  • Having a major/serious psychiatric concern (e.g., schizophrenia) as indicated by medical chart/medical provider
  • Inability to provide consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University

Durham, North Carolina, 27705, United States

Location

MeSH Terms

Conditions

NeoplasmsInfertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2025

First Posted

February 19, 2025

Study Start

February 1, 2025

Primary Completion

May 28, 2025

Study Completion

May 28, 2025

Last Updated

July 20, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations